Arphamid Therapeutics is discovering and developing novel therapeutics to prevent and reverse neuroendocrine imbalances in central nervous system disorders. We hold world-wide exclusive rights to a platform of novel and proprietary small molecules targeting RF amide receptors.
- https://www.linkedin.com/company/arphamid-therapeutics-gmbh/?viewAsMember=true
- +49 170 282 27 64
- Send an email
- Alexander Kraus
